0001179110-20-008539.txt : 20200729 0001179110-20-008539.hdr.sgml : 20200729 20200729164013 ACCESSION NUMBER: 0001179110-20-008539 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200727 FILED AS OF DATE: 20200729 DATE AS OF CHANGE: 20200729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marshall Randall CENTRAL INDEX KEY: 0001799325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 201057637 MAIL ADDRESS: STREET 1: C/O ARTARA THERAPEUTICS, INC. STREET 2: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protara Therapeutics, Inc. CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 204580525 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 646-844-0337 MAIL ADDRESS: STREET 1: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: ArTara Therapeutics, Inc. DATE OF NAME CHANGE: 20200110 FORMER COMPANY: FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC DATE OF NAME CHANGE: 20060420 4 1 edgar.xml FORM 4 - X0306 4 2020-07-27 0 0001359931 Protara Therapeutics, Inc. TARA 0001799325 Marshall Randall 6 CURVE STREET SHERBORN MA 01770 0 0 1 0 Common Stock 2020-07-27 4 S 0 338 26.08 D 640610 D Common Stock 2020-07-28 4 S 0 2600 26.85 D 638010 D Common Stock 2020-07-28 4 S 0 1811 28.63 D 636199 D Common Stock 2020-07-28 4 S 0 14243 30.42 D 621956 D Common Stock 2020-07-28 4 S 0 3493 31.53 D 618463 D Common Stock 2020-07-28 4 S 0 1200 33.09 D 617263 D Common Stock 2020-07-28 4 S 0 1650 33.79 D 615613 D Common Stock 2020-07-28 4 S 0 600 35.45 D 615013 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.06 to $26.24, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) to (8) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.38 to $27.38, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.50 to $29.41, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $31.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.01 to $32.01, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.60 to $33.34, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.65 to $34.34, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.11 to $36.00, inclusive. John D. Chambliss, as Attorney-in-Fact 2020-07-29